Aclaris Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Aclaris Therapeutics, Inc. (ACRS) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.020.120.220.190.020.070.17
Short-Term Investments0.090.080.170.160.030.000.00
Cash & Short-Term Investments0.110.120.220.190.050.070.17
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.010.010.010.000.000.00
Total Current Assets0.130.130.230.210.060.080.18
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.010.000.00
Long-Term Investments0.090.060.010.030.000.000.00
Intangible Assets0.000.000.010.010.010.000.00
Other Non-Current Assets0.000.000.000.000.000.000.07
Total Non-Current Assets0.090.070.020.050.010.010.10
Total Assets0.220.200.250.250.070.100.28
Current Liabilities
Accounts Payable0.000.030.020.020.010.020.01
Accrued Liabilities0.010.020.010.010.010.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.020.000.000.000.000.000.01
Total Current Liabilities0.030.030.020.020.010.020.03
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.010.000.03
Deferred Tax Liabilities0.000.000.000.000.000.000.00
Other Non-Current Liabilities0.010.010.030.030.000.010.00
Total Non-Current Liabilities0.030.010.040.030.020.010.03
Total Liabilities0.060.040.060.050.030.030.06
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-0.90-0.77-0.68-0.60-0.50-0.45-0.29
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.060.930.880.790.540.520.51
Shares Outstanding0.110.070.070.060.000.000.00
Total Stockholders' Equity0.160.160.200.200.040.070.22
Total Liabilities & Equity0.220.200.250.250.070.100.28